These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 9023315

  • 1. Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of pefloxacin and norfloxacin in rats.
    Delon A, Huguet F, Courtois P, Vierfond JM, Bouquet S, Couet W.
    J Pharmacol Exp Ther; 1997 Feb; 280(2):983-7. PubMed ID: 9023315
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic-pharmacodynamic modelling of the convulsant interaction between norfloxacin and biphenyl acetic acid in rats.
    Marchand S, Pariat C, Bouquet S, Courtois P, Couet W.
    Br J Pharmacol; 2000 Apr; 129(8):1609-16. PubMed ID: 10780965
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of fluoroquinolones in rats.
    Delon A, Bouquet S, Huguet F, Brunet V, Courtois P, Couet W.
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1511-5. PubMed ID: 10348785
    [Abstract] [Full Text] [Related]

  • 4. Quantitative brain microdialysis study on the mechanism of quinolones distribution in the central nervous system.
    Ooie T, Terasaki T, Suzuki H, Sugiyama Y.
    Drug Metab Dispos; 1997 Jul; 25(7):784-9. PubMed ID: 9224772
    [Abstract] [Full Text] [Related]

  • 5. Extension of the isobolographic approach to interactions studies between more than two drugs: illustration with the convulsant interaction between pefloxacin, norfloxacin, and theophylline in rats.
    Brochot C, Marchand S, Couet W, Gelman A, Bois FY.
    J Pharm Sci; 2004 Mar; 93(3):553-62. PubMed ID: 14762894
    [Abstract] [Full Text] [Related]

  • 6. Antagonistic interaction between the convulsant activities of pefloxacin and its main metabolite norfloxacin in rats.
    Delon A, Levasseur LM, Giraudon M, Bouquet S, Couet W.
    Pharm Res; 1999 Dec; 16(12):1894-7. PubMed ID: 10644081
    [No Abstract] [Full Text] [Related]

  • 7. Kinetics of drug action in disease states. XIV. Effect of infusion rate on pentylenetetrazol concentrations in serum, brain and cerebrospinal fluid of rats at onset of convulsions.
    Ramzan IM, Levy G.
    J Pharmacol Exp Ther; 1985 Sep; 234(3):624-8. PubMed ID: 3875710
    [Abstract] [Full Text] [Related]

  • 8. A new approach for early assessment of the epileptogenic potential of quinolones.
    Delon A, Pariat C, Courtois P, Bouquet S, Couet W.
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2756-8. PubMed ID: 9756792
    [Abstract] [Full Text] [Related]

  • 9. Cerebrospinal fluid transport and disposition of the quinolones ciprofloxacin and pefloxacin in rats.
    Jaehde U, Langemeijer MW, de Boer AG, Breimer DD.
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1140-6. PubMed ID: 1469626
    [Abstract] [Full Text] [Related]

  • 10. Neurotoxicity and toxicokinetics of norfloxacin in conscious rats.
    Zhang LR, Wang YM, Chen BY, Cheng NN.
    Acta Pharmacol Sin; 2003 Jun; 24(6):605-9. PubMed ID: 12791190
    [Abstract] [Full Text] [Related]

  • 11. Comparative distribution of quinolone antibiotics in cerebrospinal fluid and brain in rats and dogs.
    Ooie T, Suzuki H, Terasaki T, Sugiyama Y.
    J Pharmacol Exp Ther; 1996 Aug; 278(2):590-6. PubMed ID: 8768708
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological properties of a new fluoroquinolone on the central nervous system in rodents.
    Guiol C, Ledoussal C, Surgé JM.
    Arzneimittelforschung; 1993 Jan; 43(1):56-60. PubMed ID: 8447850
    [Abstract] [Full Text] [Related]

  • 13. The pharmacokinetics and tissue penetration of the fluoroquinolones.
    Bergeron MG.
    Clin Invest Med; 1989 Feb; 12(1):20-7. PubMed ID: 2920479
    [Abstract] [Full Text] [Related]

  • 14. Kinetics of quinolone antibiotics in rats: efflux from cerebrospinal fluid to the circulation.
    Ooie T, Suzuki H, Terasaki T, Sugiyama Y.
    Pharm Res; 1996 Jul; 13(7):1065-8. PubMed ID: 8842046
    [Abstract] [Full Text] [Related]

  • 15. Changes in brain interleukin-1beta following the coadministration of norfloxacin with biphenylacetic acid in rats.
    Zhang LR, Li XT, Tang WL, Wang YM, Cheng NN, Chen BY.
    Eur J Pharmacol; 2006 Aug 14; 543(1-3):21-6. PubMed ID: 16824509
    [Abstract] [Full Text] [Related]

  • 16. Possible involvement of nitric oxide in the quinolone-induced tendon lesions in rats.
    Kashida Y, Kato M.
    Drugs Exp Clin Res; 1997 Aug 14; 23(3-4):139-43. PubMed ID: 9403275
    [Abstract] [Full Text] [Related]

  • 17. Dose ranging pharmacokinetics and brain distribution of norfloxacin using microdialysis in rats.
    Marchand S, Chenel M, Lamarche I, Pariat C, Couet W.
    J Pharm Sci; 2003 Dec 14; 92(12):2458-65. PubMed ID: 14603491
    [Abstract] [Full Text] [Related]

  • 18. Ignoring pharmacokinetics may lead to isoboles misinterpretation: illustration with the norfloxacin-theophylline convulsant interaction in rats.
    Cadart M, Marchand S, Pariat C, Bouquet S, Couet W.
    Pharm Res; 2002 Feb 14; 19(2):209-14. PubMed ID: 11883649
    [Abstract] [Full Text] [Related]

  • 19. Effects of some excitatory amino acid antagonists and drugs enhancing gamma-aminobutyric acid neurotransmission on pefloxacin-induced seizures in DBA/2 mice.
    De Sarro G, Nava F, Calapai G, De Sarro A.
    Antimicrob Agents Chemother; 1997 Feb 14; 41(2):427-34. PubMed ID: 9021202
    [Abstract] [Full Text] [Related]

  • 20. Simultaneous central nervous system distribution and pharmacokinetic-pharmacodynamic modelling of the electroencephalogram effect of norfloxacin administered at a convulsant dose in rats.
    Chenel M, Marchand S, Dupuis A, Lamarche I, Paquereau J, Pariat C, Couet W.
    Br J Pharmacol; 2004 May 14; 142(2):323-30. PubMed ID: 15155539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.